Stay updated with breaking news from Sporegen Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: ---------- NetScientific PLC - life sciences and sustainability... | May 2, 2023
+44 (0) 203 705 9330 Destiny Pharma is a clinical stage, innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections. Its pipeline has novel microbiome-based biotherapeutics and XF drug clinical assets including NTCD-M3, a Phase 3 ready treatment for the prevention of C. difficile infection (CDI) recurrence which is the leading cause of hospital acquired infection in the US and also XF-73 nasal gel, which is in a Phase 2b clinical trial targeting the prevention of post-surgical Staphylococcal hospi...